CART19 in Hodgkin lymphoma: are we driving the right model?
Blood
.
2018 Sep 6;132(10):982-983.
doi: 10.1182/blood-2018-07-864520.
Author
Catherine S Diefenbach
1
Affiliation
1
Perlmutter Cancer Center at New York University Langone Health.
PMID:
30190350
DOI:
10.1182/blood-2018-07-864520
No abstract available
Publication types
Comment
MeSH terms
Child
Hodgkin Disease / immunology*
Humans
RNA
Receptors, Chimeric Antigen
T-Lymphocytes
Substances
Receptors, Chimeric Antigen
RNA